Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
An Early CD4+ T Cell–dependent Immunoglobulin A Response to Influenza Infection in the Absence of Key Cognate T–B Interactions
2003 Nobel
The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients
2020 Standout
Origin and evolution of pathogenic coronaviruses
2018 Standout
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Oral adjuvant activity for nasal influenza vaccines caused by combination of two trihydroxy fatty acid stereoisomers from the tuber of Pinellia ternata
2010 StandoutNobel
Pandemic Influenza Vaccines
2009
Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]
2012
The biological action of saponins in animal systems: a review
2002 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Regulation of IgA synthesis at mucosal surfaces
2004 StandoutNobel
Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice
2011
Genotype shift in human coronavirus OC43 and emergence of a novel genotype by natural recombination
2014
A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae
2003
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
Mucosal immunity and vaccines
2005 Standout
A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen
2001
Biomedical applications of biodegradable polymers
2011 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
2016
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
2020 Standout
Chronic Trigeminal Ganglionectomy or Topical Capsaicin Application to Pial Vessels Attenuates Postocclusive Cortical Hyperemia but Does Not Influence Postischemic Hypoperfusion
1991
Coronavirus envelope protein: current knowledge
2019 Standout
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
2009 StandoutNobel
Total synthesis and adjuvant activity of all stereoisomers of pinellic acid
2003 StandoutNobel
Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity
2013
Pulmonary Infection with Influenza A Virus Induces Site-Specific Germinal Center and T Follicular Helper Cell Responses
2012
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP
2011
Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin
1997
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Dysbiosis of the gut microbiota in disease
2015 Standout
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Priming of CD8+ CTL effector cells in mice by immunization with a stress protein–influenza virus nucleoprotein fusion molecule
1999
Cross‐Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine
2007
The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats
1993 Standout
Pinellic acid from the tuber of Pinellia ternata Breitenbach as an effective oral adjuvant for nasal influenza vaccine
2002
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
2016 Standout
Phagocytic antigen processing and effects of microbial products on antigen processing and T‐cell responses
1999
Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR1Note: Nucleotide sequence data reported in this paper have been submitted to GenBankTM database with the accession number AF146527 (Toxoplasma gondii genomic repetitive 529 bp fragment).1
2000 Standout
Lactic acid bacterial cell factories for gamma-aminobutyric acid
2010
Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses
1996
Poly(γ-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice
2009
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
Molecular biology of flaviviruses
2003 StandoutNobel
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
2020 Standout
KDEL-Cargo Regulates Interactions between Proteins Involved in COPI Vesicle Traffic
2001 StandoutNobel
Dengue virus life cycle: viral and host factors modulating infectivity
2010 Standout
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge
2014
Real-time RT-PCR normalisation; strategies and considerations
2005 Standout
Interactions between commensal intestinal bacteria and the immune system
2004 Standout
Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms™) and oil-in-water vaccines
1998
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Dengue Virus Type 1 Nonstructural Glycoprotein NS1 Is Secreted from Mammalian Cells as a Soluble Hexamer in a Glycosylation-Dependent Fashion
1999
Cell Biology of the Glomerular Podocyte
2003 Standout
Pathogenesis of Group A Streptococcal Infections
2000 Standout
Coronavirus Diversity, Phylogeny and Interspecies Jumping
2009
Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus Infection
2005
Antibody-Dependent Enhancement Occurs Upon Re-Infection with the Identical Serotype Virus in Feline Infectious Peritonitis Virus Infection
2008
Prostaglandins as Mediators of Reactive Hyperaemia in Kidney
1974 StandoutNatureNobel
Total synthesis, elucidation of absolute stereochemistry, and adjuvant activity of trihydroxy fatty acids
2006 StandoutNobel
Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines
1993
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays
2001
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Renal effects of drugs that inhibit prostaglandin synthesis
1980
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Cyclic di-GMP: the First 25 Years of a Universal Bacterial Second Messenger
2013 Standout
Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity
1998
Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine
1994
Molecular biology of microbial ureases
1995 Standout
Pathophysiology of obstructive nephropathy
1980
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
1992 Standout
Why the kidney glomerulus does not clog: A gel permeation/diffusion hypothesis of renal function
2003 StandoutNobel
Distribution of endogenous albumin in the rat glomerulus: Role of hemodynamic factors in glomerular barrier function
1976
Influenza Virus
2001
Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice
1993
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit
1995
CD8 T Cell-Intrinsic GITR Is Required for T Cell Clonal Expansion and Mouse Survival following Severe Influenza Infection
2010 StandoutNobel
Prostaglandins, their intermediates and precursors: Cardiovascular actions and regulatory roles in normal and abnormal circulatory systems
1979 StandoutNobel
Nasal-Associated Lymphoid Tissue Is a Mucosal Inductive Site for Virus-Specific Humoral and Cellular Immune Responses
2002
Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
1982 Standout
Human cytomegalovirus stimulates host cell RNA synthesis
1975
Effect of Intranasal Administration ofLactobacillus caseiShirota on Influenza Virus Infection of Upper Respiratory Tract in Mice
2001
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of C Aizawa being referenced
Preparation of Japanese encephalitis virus nonstructural protein NS1 obtained from culture fluid of JEV-infected Vero cells
1991
Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
1998
Antihypertensive effect of γ‐amino butyric acid enriched soy products in spontaneously hypertensive rats
2004
Molecular cloning and sequence determination of the peplomer protein gene of feline infectious peritonitis virus type I
1995
Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB
1989
Failure to abolish reactive hyperemia by indomethacin in denervated kidneys of rabbits
1977
Postocclusive reactive hyperemia in the rabbit kidney
1968
H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin.
1991
Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit
1992
Large-scale purification of Japanese encephalitis virus from infected mouse brain for preparation of vaccine
1980
Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
1996
Effect of elevated ureteral pressure on renal medullary osmolal concentration in hydropenic rabbits
1971
New nuclear ribonucleic acid in cell cultures infected with polyoma virus
1969